ROLVEDON FDA approval date

The FDA approved ROLVEDON on 9 Sep 2022.

FDA approval date
9 Sep 2022

Drug identity has not yet been verified against registry records

Also recorded as EFLAPEGRASTIM-XNST

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-09-09DayROLVEDONFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761148", "applicant_as_listed_by_fda": "SPECTRUM PHARMS", "brand_names": ["ROLVEDON"], "active_ingredients": ["EFLAPEGRASTIM-XNST"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220909", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026